FDA Commissioner Marty Makary Resigns Following Dispute Over Flavored Vapes

Resignation of FDA Commissioner

Dr. Marty Makary, the commissioner of the Food and Drug Administration (FDA), resigned on Tuesday. The departure follows weeks of mounting pressure and reports that President Donald Trump intended to fire him.

Sources indicate that Makary's resignation is tied to a dispute over the regulation of e-cigarettes. Specifically, Makary had resisted the approval of fruit-flavored vapes, a position that led to direct confrontations with the President.

Dispute Over Flavored E-Cigarettes

According to reports, Makary blocked the implementation of approvals for fruit-flavored vapes for several months. During this period, vaping executives informed President Trump that Makary was obstructing the approval of products they viewed as essential to the industry's survival.

Following the intervention of President Trump last week, the FDA abruptly changed its position. The agency authorized the first fruit-flavored e-cigarettes and issued new guidelines that loosened marketing restrictions for major manufacturers. Despite this policy shift, the tension between the commissioner and the administration persisted, leading to Makary's exit.

Internal Tensions and Industry Friction

Makary's tenure was marked by friction with both the administration and the health industry. Reports state that he spent his year in office bucking the Trump administration and creating enemies within the industry.

He faced sustained pressure from within the administration regarding his regulatory stances. Additionally, his approach as a surgeon and health researcher drew complaints from various health industry stakeholders during his time as head of the agency.

Process for Replacement

With Makary's departure, the position of FDA commissioner is now vacant. A permanent replacement must be nominated by President Trump and subsequently confirmed by a majority vote in the U.S. Senate.